ArticleBMC oral health2026
An integrated clinical and imaging-based machine learning model to determine the preoperative nature of primary operable parotid tumors.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background and purposeThe accurate preoperative classification of parotid tumors is crucial in selecting the appropriate treatment options. This study aimed to develop a machine learning model based on clinical, imaging, and laboratory test data to efficiently determine the preoperative nature of primary operable parotid tumors.
methodsA total of 779 patients with primary operable parotid tumors receiving surgical treatment from four independent clinical centers were enrolled. Standardized clinical, laboratory and multi-modality imaging indicators were extracted for model construction. We compared diagnostic performance from experienced clinicians' empirical diagnosis and ten machine learning algorithms via receiver operating characteristic (ROC) analysis on internal training/test cohorts and an independent external validation dataset.
resultIn total 779 enrolled subjects, empirical clinical prediction yielded an AUC(Area Under the Receiver Operating Characteristic Curve) of 0.83 (95% CI, 0.79-0.87), while the CatBoost model based on integrated multi-source data achieved an AUC of 0.91 (95% CI, 0.85-0.97). The CatBoost model demonstrated a sensitivity of 76%, specificity of 95%, Youden's index of 0.71, and accuracy of 92% for identifying malignant tumors.
conclusionThe results of this study demonstrate that the CatBoost model constructed based on clinical, imaging and laboratory test features exhibits certain auxiliary predictive value in the preoperative assessment of primary operable parotid tumor nature, with its overall performance slightly superior to that of traditional clinical evaluation and logistic regression models.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.